Endologix to start phase II AAA (abdominal aortic aneurysms) stent trial:
This article was originally published in Clinica
Executive Summary
Endologix is to begin a phase II clinical trial in the US of its PowerLink endoluminal stent graft for treating abdominal aortic aneurysms (AAAs). The Irvine, California firm says that analysts estimate that the global market for AAAs stents could reach $500 million by 2003.